Physician profile
Michael C Kindya
NPI 1548559834
$7,476.68
in general payments reported to CMS, 2019-2025
16 companies · $91.16 in 2025
The $91.16 reported for 2025 was less than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,151 · 2020: $1,766 · 2021: $1,313 · 2022: $1,508 · 2023: $115 · 2024: $532 · 2025: $91.16.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $738.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $737.75 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Southern Edge Orthopaedics, INC. | $5,616.45 | 2019-2022 | |
| Nalu Medical, INC. | $383.05 | 2024 | Nalu Neurostimulation System |
| Smith+Nephew, INC. | $286.09 | 2019-2022 | |
| Vericel Corporation | $198.16 | 2024-2025 | Maci |
| Arthrex, INC. | $173.60 | 2020 | |
| Stryker Corporation | $163.52 | 2019-2020 | |
| Biotissue Holdings INC. | $157.35 | 2021-2022 | |
| Pacira Pharmaceuticals Incorporated | $126.29 | 2022 | |
| Orthofix Medical, INC. | $114.90 | 2023 | Physio-Stim |
| Intuitive Surgical, INC. | $78.72 | 2019 | |
| Abbott Laboratories | $48.69 | 2021 | |
| Mid-Atlantic Surgical Systems, LLC | $41.64 | 2025 | |
| Depuy Synthes Sales INC. | $40.67 | 2021-2022 | |
| Boston Scientific Corporation | $17.17 | 2022 | |
| Janssen Pharmaceuticals, INC | $16.66 | 2021 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bioventus LLC | $13.72 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Kindya listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.